(Q80843880)
Statements
Tamoxifen vs Tamoxifen plus 13-cis-retinoic acid vs Tamoxifen plus Interferon alpha-2a as first-line endocrine treatments in advanced breast cancer: updated results of a phase II, prospective, randomised multicentre trial (English)
Matteo Dalla Chiesa
Rodolfo Passalacqua
Maria Michiara
Vittorio Franciosi
Francesco Di Costanzo
Giancarlo Bisagni
Roberta Camisa
Sebastiano Buti
Gianluca Tomasello
Giorgio Cocconi
Italian Oncology Group for Clinical Research
1 December 2007